Aleglitazar
Wikipedia on Answers.com:
Top
Aleglitazar
| Aleglitazar | |
|---|---|
 |
|
|
(2S)-2-methoxy-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]- 7-benzothiophenyl]propanoic acid |
|
|
Other names
Ro-0728804, R-1439 |
|
| Identifiers | |
| CAS number | 475479-34-6 |
| PubChem | 10274777 |
| ChemSpider | 8450255  |
| DrugBank | DB08483 |
| KEGG | D08845 |
| ChEMBL | CHEMBL519504 |
| Jmol-3D images | Image 1 Image 2 |
|
|
|
|
| Properties | |
| Molecular formula | C24H23NO5S |
| Molar mass | 437.50812 |
 (verify) (what is:  / ?)Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Aleglitazar is a peroxisome proliferator-activated receptor agonist (hence a PPAR modulator ) with affinity to PPARα and PPARγ, which is being developed by Hoffmann–La Roche for the treatment of type II diabetes.[1] It is currently in phase III clinical trials.[2] .
References
- ^ "Statement on a nonproprietary name adopted by the USAN Council: Aleglitazar". United States Adopted Names. American Medical Association. http://www.ama-assn.org/ama1/pub/upload/mm/365/aleglitazar.pdf. Retrieved 2008-08-17.
- ^ "Phase III program of Aleglitazar started". Roche. http://www.roche.com/de/media/media_releases/med-cor-2009-06-09.htm. Retrieved 2012-03-29.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Aleglitazar.
Read more